Influence of modafinil on early ejaculation - Results from a double-blind randomized clinical trial

J Psychiatr Res. 2022 Feb:146:264-271. doi: 10.1016/j.jpsychires.2021.11.015. Epub 2021 Nov 9.

Abstract

Background: For men, early ejaculation is a serious health concern. Here, we tested the influence of modafinil (Profinil®) on early ejaculation. To this end, we performed a double-blind randomized clinical trial among men with early ejaculation.

Methods: A total of 46 men with early ejaculation (mean age: 37.35 years) and in stable marital relationships with regular weekly penile-vaginal intercourse were randomly assigned either to the modafinil (100 mg) or to the placebo condition. Compounds were taken about 4-6h before intended penile-vaginal intercourse. At baseline and four weeks later at the end of the study, participants completed a series of self-rating questionnaires covering early ejaculation. Female partners also rated their male partners' early ejaculation profile.

Results: Dimensions of early ejaculation improved over time, but only so in the modafinil condition, while no improvements were observed in the placebo condition.

Conclusions: Among male adults in stable marital relationships with regular weekly penile-vaginal intercourse modafinil improved dimensions of early ejaculation, always compared to placebo. Given the strong effect of modafinil on cognitive-executive processes, it is conceivable, that modafinil acted both via physiological and cognitive-executive pathways.

Keywords: Double-blind clinical trial; Early ejaculation; Male sexual dysfunction; Modafinil; Placebo.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Coitus*
  • Double-Blind Method
  • Ejaculation*
  • Female
  • Humans
  • Male
  • Modafinil / pharmacology
  • Surveys and Questionnaires

Substances

  • Modafinil